{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:F4JCU0",
      "entity_text" : "SUA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "At week 24, the percentage of subjects with SUA levels < = 7.0 mg/dl was higher in the febuxostat 80 mg/day group (80.6% [129 responders]) compared with the febuxostat 40 mg/day group (67.3% [101 responders]) and the allopurinol 300 mg/day group (68.5% [111 responders]).",
  "reading_complete" : "2020-07-28T17:22:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:15:21Z",
  "trigger" : "levels",
  "evidence" : [ "SUA levels" ],
  "pmc_id" : "6858416",
  "score" : 0
}